Arpad Szallasi Selected Research

TRPV Cation Channels

7/2019	TRPV1 Antagonists as Novel Anti-Diabetic Agents: Regulation of Oral Glucose Tolerance and Insulin Secretion Through Reduction of Low-Grade Inflammation?
1/2011	Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials.
1/2011	Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention.
2/2009	Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade.
11/2006	TRPV1: a therapeutic target for novel analgesic drugs?
9/2005	Piperine: researchers discover new flavor in an ancient spice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arpad Szallasi Research Topics

Disease

15	Pain (Aches) 01/2022 - 11/2006
6	Neoplasms (Cancer) 01/2022 - 05/2007
6	Inflammation (Inflammations) 07/2019 - 08/2002
3	Hyperalgesia 01/2011 - 08/2002
3	Neuralgia (Stump Neuralgia) 01/2010 - 07/2002
2	Hyperthermia 01/2020 - 02/2009
2	Wounds and Injuries (Trauma) 01/2020 - 01/2010
2	Overactive Urinary Bladder (Overactive Bladder) 04/2015 - 01/2011
2	Asthma (Bronchial Asthma) 05/2014 - 06/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 09/2013 - 07/2009
2	Intractable Pain 09/2013 - 05/2007
2	Migraine Disorders (Migraine) 05/2007 - 11/2006
1	Mental Disorders (Mental Disorder) 01/2022
1	Burns 01/2020
1	Chronic Pain 01/2018
1	Disease Progression 11/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2017
1	Chronic Cough 04/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2014
1	Cardiomegaly (Heart Hypertrophy) 05/2014
1	Obesity 05/2014
1	Leiomyosarcoma 01/2014
1	Thrombocytosis (Thrombocythemia) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Cancer Pain 09/2012
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2012
1	Lung Diseases (Lung Disease) 01/2012
1	Infections 01/2010
1	Endometrioid Carcinoma 04/2008
1	Wolffian tumor 04/2008
1	HIV Infections (HIV Infection) 02/2008
1	Weight Gain 01/2008
1	Pancreatitis 01/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2007
1	Neoplasm Metastasis (Metastasis) 04/2005
1	Pruritus (Itching) 07/2002

Drug/Important Bio-Agent (IBA)

8	Capsaicin (Zostrix)FDA Link 01/2020 - 07/2002
6	Pharmaceutical PreparationsIBA 01/2022 - 06/2012
6	TRPV Cation ChannelsIBA 07/2019 - 09/2005
3	Glucose (Dextrose)FDA LinkGeneric 07/2019 - 01/2008
3	resiniferatoxinIBA 09/2013 - 01/2011
2	Ion Channels (Ion Channel)IBA 01/2018 - 01/2009
2	Analgesics (Analgesic Drugs)IBA 01/2009 - 05/2007
1	Transient Receptor Potential ChannelsIBA 01/2018
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2017
1	Biological ProductsIBA 01/2014
1	TRPC6 Cation ChannelIBA 06/2012
1	NeurotoxinsIBA 01/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2009
1	TRPV1 receptorIBA 01/2009
1	Opiate AlkaloidsIBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 04/2008
1	ParaffinIBA 04/2008
1	SB 705498IBA 11/2006
1	anandamide (arachidonylethanolamide)IBA 08/2002
1	BradykininIBA 08/2002
1	EndocannabinoidsIBA 08/2002
1	Nerve Growth Factor (NGF)IBA 08/2002
1	Protein Kinase CIBA 08/2002
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 02/2008
2	Drug Therapy (Chemotherapy) 01/2012 - 04/2005
1	Adjuvant Chemotherapy 01/2014
1	Analgesia 09/2013
1	Injections 09/2013
1	Pain Management 01/2009
1	Hysterectomy 04/2008
1	Salpingo-oophorectomy 04/2008